dengu
virus
dv
occur
four
antigen
relat
distinct
serotyp
transmit
human
aed
aegypti
mosquito
virus
gener
caus
either
benign
syndrom
dengu
fever
df
sever
capillari
leakag
syndrom
dengu
haemorrhag
feverdengu
shock
syndrom
dhfdss
basu
chaturvedi
dv
affect
human
age
group
worldwid
part
world
mainli
paediatr
public
health
problem
wherea
other
thailand
dengu
infanc
also
seriou
medic
concern
pancharoen
thisyakorn
infant
dhfdss
first
report
halstead
et
al
dhfdss
occur
infant
year
age
born
dengueimmun
mother
children
year
older
immun
one
serotyp
dv
experienc
infect
second
serotyp
asia
dengu
diseas
predominantli
affect
children
among
lead
caus
hospit
death
halstead
et
al
infant
repres
children
hospit
dhf
thailand
pancharoen
thisyakorn
vietnam
chau
et
al
myanmar
halstead
et
al
indonesia
graham
et
al
sri
lanka
luca
mendi
india
kabilan
et
al
approxim
onequart
case
dss
halstead
et
al
kalayanarooj
nimmannitya
america
incid
dhf
highest
among
infant
venezuela
san
et
al
agerel
differ
identifi
preval
dengu
diseas
specif
clinic
manifest
infant
high
risk
dhfdss
south
east
asia
agespecif
incid
infant
dhf
per
person
age
month
disappear
age
month
caped
et
al
data
first
publish
studi
estim
agespecif
dengu
hospit
rate
bangkok
metropolitan
area
show
hospit
rate
infant
dhfdss
twice
children
bangkok
year
halstead
et
al
later
report
infant
dhfdss
constitut
thai
vietnames
myanmar
indonesian
infant
children
hospit
dhf
halstead
et
al
thailand
dengu
infanc
year
age
seriou
medic
problem
constitut
rate
observ
two
differ
hospit
dv
infect
pancharoen
thisyakorn
howev
death
rate
low
due
earli
diagnosi
prompt
treatment
witayathawornwong
dengu
infanc
also
report
sri
lanka
india
aggarw
et
al
luca
mendi
dengu
infanc
constitut
total
dv
infect
outbreak
chennai
india
major
burden
dv
diseas
lie
infant
children
year
age
kabilan
et
al
countri
shorter
nonendem
histori
dv
circul
also
report
case
princip
adolesc
adult
popul
countri
diseas
endem
distribut
burden
diseas
similar
dhfdss
andor
sever
clinic
manifest
infant
children
da
cunha
et
al
rahman
et
al
differ
may
due
variat
circul
dv
serotyp
strain
chang
suscept
infect
enhanc
diseas
due
immun
statu
vaughn
et
al
dengu
welldocu
publichealth
burden
mani
develop
countri
four
serotyp
dv
caus
spectrum
outcom
human
rang
asymptomat
infect
mild
clinic
signific
sever
diseas
dhfdss
character
system
capillari
leakag
thrombocytopaenia
hypovolaem
shock
tabl
burden
sever
ill
lie
predominantli
infant
month
age
halstead
et
al
sever
clinic
manifest
dhfdss
dss
alon
preval
infant
follow
children
adult
hammond
et
al
manifest
convuls
hepat
dysfunct
commonli
affect
infant
older
children
fatal
rate
four
time
higher
infant
kalayanarooj
nimmannitya
frequenc
intern
haemorrhag
increas
age
affect
one
seven
adult
hammond
et
al
risk
present
sign
dhfdss
year
age
calcul
seen
infant
children
age
year
signific
risk
sever
dengu
wherea
adult
adolesc
year
older
risk
significantli
less
odd
ratio
hammond
et
al
haematocrit
seen
higher
frequenc
among
infant
infant
older
children
mean
platelet
count
infant
significantli
less
older
children
nearli
infant
platelet
count
kabilan
et
al
total
white
blood
cell
count
total
lymphocyt
count
significantli
higher
infant
children
coryza
nauseavomit
rash
petechia
haemorrhag
manifest
significantli
higher
infant
younger
children
older
children
witayathawornwong
highgrad
fever
hepatomegali
soundrav
et
al
rash
oedema
lower
extrem
retroorbit
puffi
vomit
convuls
common
infant
older
children
kabilan
et
al
infant
dhfdss
present
bleed
case
cyanosi
ascit
shock
well
hepatomegali
et
al
transplacent
transmiss
dv
report
either
viru
isol
thaithumyanon
et
al
detect
viral
nucleic
acid
phongsamart
et
al
research
demonstr
presenc
antidv
igm
sera
newborn
documentari
proof
vertic
transmiss
viru
et
al
dv
infect
pregnanc
pose
signific
risk
mother
child
matern
antibodi
harm
foetu
newborn
tabl
recent
report
malaysia
chin
et
al
report
vertic
transmiss
acut
dengu
subject
deliv
normal
term
babi
girl
spontan
vagin
deliveri
recov
unev
without
peripartum
haemorrhag
despit
presenc
thrombocytopaenia
babi
girl
develop
lowgrad
fever
day
except
transient
thrombocytopaenia
recov
unev
follow
day
mild
ill
chin
et
al
present
infant
mild
ie
mild
fever
subsid
week
unev
hepatomegali
thrombocytopenia
coagulopathi
involv
bleed
disord
respiratori
distress
dhfdss
death
clinic
featur
neonat
dv
infect
show
fever
vasomotor
problem
blotch
domin
trait
follow
hepatomegali
thrombopaenia
dhf
one
studi
two
mother
acut
dengu
day
birth
infant
one
mother
worsen
proteinur
pregnancyinduc
hypertens
liver
dysfunct
coagulopathi
requir
multipl
transfus
whole
blood
platelet
fresh
frozen
plasma
male
infant
ill
birth
develop
respiratori
distress
larg
uncontrol
left
intracerebr
haemorrhag
die
multiorgan
failur
day
life
dv
type
isol
infant
blood
igm
antibodi
specif
dv
detect
mother
blood
second
mother
milder
clinic
cours
gave
birth
femal
infant
thrombocytopaen
birth
unev
hospit
dv
type
recov
mother
blood
igm
antibodi
specif
dv
detect
infant
blood
report
highlight
appar
rare
occurr
vertic
transmiss
dv
human
also
potenti
risk
death
infect
neonat
chye
et
al
passiv
transfer
matern
dengu
antibodi
foetus
influenc
occurr
sever
develop
diseas
et
al
antibodi
dv
dengueinfect
mother
cross
placenta
caus
newborn
infant
develop
dhfdss
easili
primarili
infect
dv
antidengu
activ
found
lipid
compon
human
milk
colostrum
suggest
breast
feed
protect
infant
dv
endem
area
dengu
infect
chong
lin
report
suggest
dv
caus
teratogen
abort
intrauterin
growth
retard
foetu
pregnanc
chong
lin
wherea
report
dv
may
respons
foetal
death
carl
et
al
low
birth
weight
greater
frequenc
prematur
birth
increas
foetal
distress
restrepo
et
al
nine
women
infect
df
earli
pregnanc
receiv
amniocentesi
chromosom
analysi
reveal
normal
level
amniot
fluid
matern
sera
within
normal
rang
chong
lin
endem
area
dengu
infect
caus
acut
febril
ill
pregnant
women
sepsislik
ill
neonat
vertic
infect
result
longterm
sequela
phongsamart
et
al
antibodi
produc
dv
infect
divid
typespecif
neutral
antibodi
crossreact
nonneutr
antibodi
crossneutr
antibodi
among
four
dv
kuran
takasaki
stephenson
crossreact
nonneutr
antibodi
remain
earlier
heterogen
dv
infect
enhanc
cellular
uptak
dv
enhanc
infect
also
call
enhanc
antibodi
caus
ade
infect
review
chaturvedi
et
al
dhf
occur
almost
exclus
two
set
children
adult
becom
infect
second
dv
serotyp
initi
primari
dv
infect
differ
serotyp
infant
primari
dv
infect
whose
mother
dv
immun
ade
model
suggest
individu
develop
dhf
although
antibodi
dv
blood
antibodi
neutral
viru
rather
bind
enhanc
uptak
certain
fc
receptorbear
monocytesmacrophag
thu
increas
viral
burden
result
sever
diseas
review
halstead
secondari
infect
caus
time
dhf
case
primari
infect
neutral
antibodi
reduc
viraemia
level
wherea
crossreact
nonneutr
enhanc
antibodi
may
increas
individu
infect
one
serotyp
dv
usual
protect
subsequ
infect
serotyp
homotyp
infect
halstead
crossprotect
infect
differ
serotyp
heterotyp
infect
shown
short
term
follow
infect
report
show
individu
neutral
antibodi
develop
symptom
upon
infect
suggest
neutral
antibodi
alway
work
protect
subsequ
homolog
infect
endi
et
al
neutral
antibodi
import
protect
dv
infect
passiv
transfer
polyclon
monoclon
mab
neutral
antibodi
confer
protect
lethal
challeng
murin
model
chaturvedi
et
al
one
studi
report
enhanc
antibodi
correl
viraemia
level
laoprasopwattana
et
al
demonstr
mab
show
enhanc
activ
also
show
neutral
activ
addit
commerci
rabbit
complement
fresh
human
sera
ade
assay
system
abolish
enhanc
activ
mab
yamanaka
et
al
complement
compon
restrict
ade
antiflaviviru
antibodi
igg
subclassspecif
manner
cell
cultur
mice
igg
subclass
bind
avidli
induc
minim
ade
presenc
wherea
subclass
bind
weakli
enhanc
infect
mehlhop
et
al
site
attach
antibodi
dv
may
determin
ade
human
mab
direct
fusion
loop
near
junction
domain
ii
envelop
protein
enhanc
viraemia
rhesu
monkey
goncalvez
et
al
domain
iii
antibodi
mediat
neutral
protect
function
pierson
et
al
dv
infect
cell
via
ade
suppress
nitric
oxid
radic
disrupt
transcript
ino
gene
transcript
factor
block
activ
also
suppress
transcript
translat
interleukin
il
interferon
ifn
tumour
necrosi
factor
tnf
express
synthesi
antiinflammatori
cytokin
enhanc
thu
besid
facilit
entri
process
dv
infect
via
ade
also
alter
innat
adapt
intracellular
antivir
mechan
result
unrestrict
dv
replic
cell
chareonsirisuthigul
et
al
similar
decreas
nitric
oxid
increas
blood
level
seen
dhf
patient
ubol
et
al
chaturvedi
nagar
furthermor
dv
infect
fcrbear
mast
cellbasophil
cell
line
ade
result
massiv
induct
apoptosi
brown
et
al
abund
ifn
type
gene
transcript
peripher
blood
mononuclear
cell
vietnames
dss
patient
lower
dhf
patient
without
shock
simmon
et
al
role
ade
dhfdss
summar
fig
role
matern
denguespecif
antibodi
develop
dhfdss
caus
infant
report
klik
evid
dv
infect
low
geometr
mean
titr
dengu
serotyp
children
month
age
beyond
demonstr
dv
infect
rate
increas
month
age
onward
matern
igg
antibodi
known
cross
placent
barrier
provid
protect
newborn
infect
antibodi
titr
newborn
proport
matern
antibodi
level
perret
et
al
first
report
dengu
antibodi
cross
placent
barrier
human
ventura
antobodi
suspect
sensit
infant
dhfdss
cord
blood
leucocyt
neonat
matern
dengu
antibodi
support
replic
vitro
neonat
without
matern
antibodi
marchett
report
cord
blood
infant
born
dengueimmun
mother
contain
potent
enhanc
factor
gradual
decay
age
absent
neonat
born
nonimmun
mother
support
hypothesi
sever
primari
dhf
shock
seen
bangkok
infant
relat
matern
immun
statu
marchett
et
al
dhf
children
adult
typic
associ
secondari
infect
caus
dv
serotyp
distinct
present
individu
first
expos
dv
graham
et
al
contrast
dhf
occur
primari
dv
infect
infant
born
dengueimmun
mother
simmon
et
al
bimod
age
distribut
dhf
one
earliest
clue
alert
research
immun
enhanc
theori
age
peak
occur
month
year
children
secondari
infect
dhf
higher
initi
plasma
viral
load
wang
et
al
klik
colleagu
investig
dhf
infant
found
matern
dengu
neutral
antibodi
titr
age
infant
strongli
correl
actual
age
dhfdss
occur
infant
correl
age
maximum
enhanc
activ
dengu
infect
mononuclear
phagocyt
predict
critic
time
occurr
dhfdss
observ
approxim
month
time
calcul
matern
dengueneutr
antibodi
degrad
protect
level
addit
sera
mother
infant
dhfdss
enhanc
dv
infect
slightli
greater
degre
sera
mother
infant
pyrexia
unknown
origin
toddler
dhfdss
show
matern
dengu
antibodi
play
dual
role
first
protect
later
increas
risk
develop
dhfdss
infant
becom
infect
dengu
virus
klik
et
al
birth
matern
antibodi
protect
infant
dengu
infect
igg
antibodi
catabol
period
risk
enhanc
infect
ensu
follow
turn
loss
enhanc
antibodi
correspond
declin
risk
dhfdss
klik
et
al
fig
enhanc
infant
infect
cord
blood
antibodi
also
describ
natur
infect
kitten
born
queen
immun
felin
infecti
periton
viru
horzinek
osterhau
matern
dengu
antibodi
decay
studi
followup
period
report
matern
haemagglutin
inhibit
antibodi
dv
disappear
age
month
case
watanaveeradej
et
al
anoth
studi
infant
still
lower
titr
neutral
antibodi
least
one
dv
serotyp
one
infant
undifferenti
febril
ill
due
infect
week
seen
neutral
antibodi
four
serotyp
pengsaa
et
al
healthi
vietnames
infant
strong
tempor
associ
fcdepend
dv
infectionenhanc
activ
neat
plasma
agerel
epidemiolog
sever
dengu
prospect
nest
casecontrol
studi
primari
infect
infanc
shown
full
rang
diseas
sever
librati
et
al
diseas
sever
infant
primari
infect
associ
robust
immun
respons
possibl
consequ
higher
viral
burden
vivo
chau
et
al
total
igg
dvreactiv
igg
higher
cord
plasma
mother
plasma
matern
dvneutral
e
proteinreact
igg
titr
declin
measur
level
infant
month
age
dvreactiv
igg
whole
dv
virion
persist
month
age
infant
dv
infect
infant
frequent
subclin
window
month
age
virionbind
nonneutr
igg
could
facilit
ade
chau
et
al
dvinfect
cell
releas
high
proport
immatur
prmcontain
virion
lack
abil
infect
cell
howev
becom
highli
infecti
upon
interact
prm
antibodi
secondari
infect
primari
infect
infant
born
dengueimmun
mother
immatur
particl
potenti
highli
infecti
henc
may
contribut
develop
sever
diseas
rodenhuiszybert
et
al
cellular
immun
respons
coordin
differenti
heterogen
popul
antigenspecif
cell
effect
erad
pathogen
provid
protect
reinfect
antigenexpos
cell
identifi
three
subset
shortliv
effector
cell
central
memori
cell
tcm
effector
memori
cell
earli
delin
cell
regul
specif
transcript
factor
cytokin
latter
also
respons
mainten
tcm
cell
heterogen
cd
cell
play
role
dv
infect
summar
fig
littl
known
gener
tcell
pool
healthi
children
normal
peripher
blood
naiv
tcell
number
high
newborn
declin
increas
age
memori
tcell
number
appear
less
depend
age
shown
foetal
life
matur
tcell
respons
elicit
viral
parasit
infect
king
et
al
marchant
et
al
cell
capabl
produc
increas
progress
age
et
al
signific
age
correl
observ
expressionreleas
mrna
level
cytokin
increas
neonat
period
infanc
express
usual
correl
express
monocyt
also
agecorrel
et
al
suggest
increas
tcell
divis
young
mice
children
may
driven
high
level
growth
factor
antigen
exposur
first
year
life
physiolog
immatur
immun
system
birth
attribut
preval
suppressor
factor
foetal
life
antigen
naiveti
regulatori
cell
treg
consist
heterogen
collect
cell
abil
suppress
activ
prolifer
cell
immun
respons
whole
treg
cell
inhibit
protect
antivir
respons
enhanc
diseas
progress
cell
block
tcell
activ
limit
viral
replic
well
consequ
immunopatholog
furthermor
inhibit
antivir
tcell
respons
treg
cell
could
lead
viral
persist
rapid
diseas
progress
review
chaturvedi
et
al
treg
cell
known
present
higher
frequenc
human
foetal
ontogeni
cupedo
et
al
may
import
context
perinat
infect
cellular
immun
respons
infant
dv
infect
well
studi
dengu
immunopathogenesi
focus
sequenti
dv
infect
phenomenon
suggest
sever
diseas
result
amplifi
cytokin
releas
caus
dengu
infect
occur
presenc
tcell
memori
rothman
enni
model
explain
dhfdss
first
dengu
infect
fig
plasma
level
cytokineschemokin
gener
higher
infant
dss
antigendriven
inflammatori
cytokin
releas
hypothes
contribut
dengu
capillaryleakag
syndrom
chemokin
express
may
earli
event
dengu
might
play
role
immunopathogenesi
concentr
cytokin
chemokin
mig
rant
plasma
sampl
except
rant
infant
dss
high
consist
relationship
magnitud
immun
inflamm
capillari
leakag
chau
et
al
correct
made
april
onlin
public
correct
paragraph
plasma
level
correl
viraemia
rant
mig
correl
hepat
dysfunct
acut
primari
dengu
infant
plasma
level
cytokin
chemokin
infant
significantli
correl
viral
load
level
measur
diseas
sever
includ
thrombocytopaenia
haematocrit
dengu
diseas
grade
infant
significantli
correl
plasma
dv
load
sampl
ip
express
hepatocyt
dvinfect
mice
promot
infiltr
natur
killer
cell
hepat
tissu
chen
et
al
dv
appear
compet
attach
heparin
sulphat
cell
surfac
suggest
might
antidv
activ
beyond
immunolog
properti
chen
et
al
plasma
level
rant
mig
associ
liver
transaminas
level
may
suggest
relationship
hepat
dysfunct
chemokin
activ
includ
recruit
lymphocyt
site
infect
dhf
secondari
infect
also
associ
significantli
greater
plasma
concentr
inflammatori
cytokin
chaturvedi
et
al
juffri
et
al
increas
frequenc
activ
lymphocyt
compar
patient
milder
diseas
mongkolsapaya
et
al
presum
respons
higher
viral
burden
dhf
cellular
immun
activ
associ
dengu
sever
primari
infect
infant
well
secondari
infect
older
children
juffri
et
al
concept
antigendriven
immun
activ
infant
consist
observ
older
children
secondari
infect
rel
high
earli
viraemia
level
robust
activ
lymphocyt
inflammatori
cytokin
respons
found
associ
diseas
greater
sever
juffri
et
al
infant
primari
acut
dhf
show
signific
posit
associ
dengu
sever
marker
lymphocyt
activ
chau
et
al
cell
may
play
role
immunopathogenesi
secondari
infect
respons
expect
earlier
domin
robust
serotypecrossreact
respons
although
cell
contribut
littl
resolut
viraemia
immunopathogenesi
infant
primari
dengu
mongkolsapaya
et
al
find
describ
indic
matern
deriv
dvreactiv
igg
determin
viral
load
pathogenesi
infant
ade
infect
dv
ade
inhibit
induct
inosnitr
oxid
dendrit
cellsmacrophag
sever
studi
increas
suscept
newborn
variou
infect
attribut
defici
secret
review
et
al
treg
cell
suppress
protect
antivir
respons
acceler
diseas
progress
hand
block
tcell
activ
thu
limit
viral
replic
activationassoci
immunopatholog
interest
note
find
simian
immunodefici
viru
siv
infect
infant
macaqu
monkey
larg
number
highli
suppress
treg
cell
cell
directli
inhibit
tcell
respons
siv
associ
transient
tcell
respons
limit
antibodi
product
hartiganoconnor
et
al
suppressor
cell
known
present
mice
human
infect
dv
tandon
et
al
chaturvedi
chaturvedi
et
al
et
al
similar
mechan
may
work
infant
patient
dhfdss
may
partli
explain
vulner
human
infant
dv
infect
high
viral
burden
vivo
may
elicit
consequ
immun
activ
may
associ
diseas
sever
may
contribut
denguerel
vasculopathi
situat
burden
viral
antigen
magnitud
immun
respons
import
determin
clinic
respons
suggest
high
peak
viraemia
necessari
suffici
caus
plasma
leakag
memori
dvspecif
cell
induc
primari
dv
infect
reactiv
heterolog
viral
serotyp
secondari
infect
expand
high
level
produc
skew
cytokin
profil
rothman
result
cytokin
tsunami
chaturvedi
et
al
chaturvedi
nagar
pregnanc
small
number
variou
type
cell
transfer
mother
foetu
via
placenta
breastfeed
zhou
et
al
includ
matern
erythrocyt
platelet
granulocyt
lymphocyt
desai
creger
mold
report
substanti
number
matern
cell
cross
placenta
foetal
lymph
node
induc
develop
treg
cell
suppress
foetal
antimatern
immun
persist
least
earli
adulthood
furthermor
report
foetal
cell
highli
respons
stimul
absenc
treg
cell
worth
investig
whether
dvspecif
memori
cell
also
cross
placenta
whether
suffici
number
initi
cytokin
tsunami
sever
explan
may
offer
faster
diseas
progress
infant
may
due
lower
intens
adapt
tcell
respons
result
unrestrict
viral
replic
infant
lower
frequenc
antigenspecif
helper
th
cell
cell
bia
furthermor
infant
dendrit
cell
express
lower
level
major
histocompat
complex
adhes
molecul
abil
produc
lower
due
limit
express
adaptor
protein
limit
activ
downstream
signal
molecul
respons
tolllik
receptor
ligat
reduc
may
compromis
prime
tcell
respons
dv
infant
tabl
larg
bodi
data
suggest
dhfdss
occur
secondari
dengu
infect
adult
children
main
induc
situat
ade
memori
cell
situat
infant
complex
dhfdss
may
accompani
primari
dv
infect
matern
deriv
specif
igg
may
present
memori
cell
also
present
known
dv
infect
influenc
tcell
dynam
infant
complex
pathogenesi
dhfdss
primari
dengu
infant
confound
differ
agerel
vascular
physiolog
immunolog
matur
matern
deriv
memori
cell
overwhelm
treg
respons
offer
uniqu
challeng
investig
result
infant
may
directli
applic
older
childrenadult
secondari
infect
reduct
viral
burden
antivir
drug
suppress
immun
activ
may
help
improv
clinic
outcom
infant
also
children
adult
dengu
studi
show
whether
interfer
regulatori
control
cell
assist
control
dengu
diseas
newer
strategi
need
prevent
treatment
dhfdss
magnitud
dhfdss
infant
uniqu
model
provid
immens
challeng
understand
pathogenesi
need
focu
attent
dengu
diseas
infant
